Asieris MediTech (Hong Kong) Co., Ltd. is a subsidiary of Asieris Pharmaceuticals, a global biotech company specializing in the development of innovative drugs for the treatment of genitourinary tumors and related diseases. Established in 2010, Asieris is committed to leading the development of new drugs and has made significant progress in clinical trials and commercialization strategies. The company focuses on providing integrated diagnosis-to-treatment solutions and has a strong pipeline of products aimed at improving patient outcomes.